22410-5 |
Lymphocytic choriomeningitis virus Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Lymphocytic choriomeningitis virus IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22410-5 |
|
|
|
|
Both |
|
|
|
0 |
LCMV IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; LCMV; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22411-3 |
Lymphocytic choriomeningitis virus Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Lymphocytic choriomeningitis virus IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22411-3 |
|
|
|
|
Both |
|
|
|
0 |
LCMV IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; LCMV; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22412-1 |
Saccharopolyspora rectivirgula Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Saccharopolyspora rectivirgula Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22412-1 |
|
|
|
|
Both |
|
|
|
0 |
S rectivirgula Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; F retivirgula; Faenia rectivirgula; Farmers lung; ID; Infectious Disease; InfectiousDisease; M faeni; m212; m22; m50; Mcropolyspra; Microbiology; Micropolyspora faeni; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rm212; S rectivirgula; S retivirgula; Screen; Serum; SR; UniversalLabOrders |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22413-9 |
Mumps virus Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Mumps virus Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22413-9 |
|
|
|
|
Both |
|
|
|
0 |
MuV Ab Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; MuV; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22414-7 |
Mumps virus Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Mumps virus Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22414-7 |
|
|
|
|
Both |
|
|
|
0 |
MuV Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; MuV; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22415-4 |
Mumps virus Ab.IgG |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Mumps virus IgG Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22415-4 |
|
|
|
|
Both |
|
|
|
0 |
MuV IgG Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; MuV; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; UniversalLabOrders |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22416-2 |
Mumps virus Ab.IgG |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Mumps virus IgG Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22416-2 |
|
|
|
|
Both |
|
|
|
0 |
MuV IgG Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; MuV; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22417-0 |
Mumps virus Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Mumps virus IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22417-0 |
|
|
|
|
Both |
|
|
|
0 |
MuV IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; MuV; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22418-8 |
Mumps virus Ab.IgM |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Mumps virus IgM Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22418-8 |
|
|
|
|
Both |
|
|
|
0 |
MuV IgM Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; MuV; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22419-6 |
Mumps virus Ab.IgM |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Mumps virus IgM Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22419-6 |
|
|
|
|
Both |
|
|
|
0 |
MuV IgM Titr CSF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; MuV; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
2242-6 |
Estradiol.free |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Estradiol Free [Mass/volume] in Serum or Plasma |
|
DEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
2242-6 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated Estradiol Free SerPl-mCnc |
|
|
|
Y |
|
17-beta estradiol; Chemistry; E2; Estradiol Free; Estradiol.non-protein bound; FR; Level; Mass concentration; Non-protein bound; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.36 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
22420-4 |
Mumps virus Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Mumps virus IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22420-4 |
|
|
|
|
Both |
|
|
|
0 |
MuV IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; MuV; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22421-2 |
Mycobacterium avium subspecies paratuberculosis Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Mycobacterium avium ss paratuberculosis Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22421-2 |
|
|
|
|
Both |
|
|
|
0 |
M avium paraTB Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Johnes disease; M avium; M avium paraTB; Microbiology; Myco; Mycobact; Mycobacterium paratuberculosis; Ordinal; Paratuberculosis; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; ssp; Tuberculosis; Vet; Veterinary |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22422-0 |
Mycoplasma gallisepticum Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Mycoplasma gallisepticum Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22422-0 |
|
|
|
|
Both |
|
|
|
0 |
M gallisep Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian mycoplasmosis; Chronic respiratory disease; ID; Infectious Disease; InfectiousDisease; M gallisep; M gallisepticum; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22423-8 |
Mycoplasma hominis Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Mycoplasma hominis Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22423-8 |
|
|
|
|
Both |
|
|
|
0 |
M hominis Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; M hominis; Metamycoplasma hominis; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22424-6 |
Mycoplasma meleagridis Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Mycoplasma meleagridis Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22424-6 |
|
|
|
|
Both |
|
|
|
0 |
M meleagridis Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; M meleagridis; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22425-3 |
Mycoplasma pneumoniae Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Mycoplasma pneumoniae Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22425-3 |
|
|
|
|
Both |
|
|
|
0 |
M pneumo Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Enzootic pneumonia; ID; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22426-1 |
Mycoplasma pneumoniae Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Mycoplasma pneumoniae IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22426-1 |
|
|
|
|
Both |
|
|
|
0 |
M pneumo IgG Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Enzootic pneumonia; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22427-9 |
Mycoplasma pneumoniae Ab.IgM |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Mycoplasma pneumoniae IgM Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22427-9 |
|
|
|
|
Both |
|
|
|
0 |
M pneumo IgM Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Enzootic pneumonia; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
22428-7 |
Mycoplasma sp Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Mycoplasma sp Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22428-7 |
|
|
|
|
Both |
|
|
|
0 |
Mycoplasma Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; species; spp; SR |
2.73 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
22429-5 |
Mycoplasma synoviae Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Mycoplasma synoviae Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22429-5 |
|
|
|
|
Both |
|
|
|
0 |
M synoviae Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; M synoviae; Microbiology; Myco; Mycoplas; Mycoplasm; Mycoplasmosis; Mycoplsm; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.56 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
2243-4 |
Estradiol |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/L;pg/mL |
|
|
|
|
|
|
CHEM |
|
2243-4 |
|
|
|
|
Both |
|
|
|
0 |
Estradiol SerPl-mCnc |
|
|
|
Y |
|
17-beta estradiol; Chemistry; E2; Gyn; Gynecology; Level; Mass concentration; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; UniversalLabOrders |
2.73 |
1 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
130 |
22430-3 |
Neisseria gonorrhoeae Ab |
Titr |
Ser |
Pt |
Qn |
|
|
DISCOURAGED |
Neisseria gonorrhoeae Ab [Titer] in Serum |
|
MIN |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22430-3 |
|
|
|
|
Both |
|
|
|
0 |
N gonorrhoea Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); GC; Gono; Gonorrhea; ID; Infectious Disease; InfectiousDisease; Microbiology; N gonorrhoea; N gonorrhoeae; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Titer; Titered; Titre; Ttr |
2.73 |
1.0n |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
22431-1 |
Neisseria meningitidis serogroup Y Ab |
Titr |
XXX |
Pt |
SemiQn |
|
|
ACTIVE |
Neisseria meningitidis serogroup Y Ab [Titer] in Specimen |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
22431-1 |
|
|
|
|
Both |
|
|
|
0 |
N men sg Y Ab Titr Spec |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; Misc; Miscellaneous; N men; N men serogroup; N men sg Y; N men sg Y Ab; N menigitidis; N meningitidis; Neisseria meningitidis group Y; Neisseria meningitidis type Y; Other; Point in time; Random; SmQn; Spec; Titer; Titered; Titre; To be specified in another part of the message; Ttr; Unspecified |
2.75 |
1.0n |
|
|
|
|
|
|
|
{titer} |
|
|
Added 'serogroup' to the Component for clarification. |
0 |
22432-9 |
Neospora caninum Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Neospora caninum Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
22432-9 |
|
|
|
|
Both |
|
|
|
0 |
N caninum Ab Ser Ql |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; N caninum; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serum; SR; Vet; Veterinary |
2.67 |
1.0n |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |